GSTM1 and interstitial lung disease: A recent study chose an absolute decline in the FVC of ≥5% over 1 year and an absolute decline in DLCO (corrected for Hb) of ≥10% within 1 year of follow-up as criteria for disease progression in progressive fibrosing ILD (PPF) [41].